3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Colorectal Neoplasms
2
Smoking Cessation
1
Sedentary Behavior
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pain
1
Myelodysplastic Syndromes
1
Motor Activity
1
Metastatic Pancreatic Adenocarcinoma
1
Malignant Hepatobiliary Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hematopoietic and Lymphoid System Neoplasm
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Chronic Pain
1
Chronic Disease
1
Cervical Cancer Screening
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Pain
1
COVID-19
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Alzheimer Disease
1
Agnosia
1
Interventions
Oxaliplatin
19
pembrolizumab
13
Fluorouracil
12
Leucovorin
11
Capecitabine
11
Paclitaxel
10
Gemcitabine
8
Docetaxel
8
zolbetuximab
6
cemiplimab
6
Cisplatin
6
Albumin-Bound Paclitaxel
6
durvalumab
5
Ramucirumab
5
Radiotherapy
5
Irinotecan
4
Cyclophosphamide
4
130-nm albumin-bound paclitaxel
4
trastuzumab deruxtecan
3
tislelizumab
3
lenvatinib
3
enzalutamide
3
darolutamide
3
atezolizumab
3
Trastuzumab
3
Taxes
3
S 1 (combination)
3
Radiosurgery
3
Pemetrexed
3
Nivolumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Telemedicine
×
1 year
×
Clear all
No trials found.